MyAverix Finance
AU · Healthcare
ECS Botanics Holdings Ltd (ECS)
Drug Manufacturers - Specialty & Generic
ECS Botanics Holdings Ltd (ECS) is listed on AU in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $7.98M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ECS
ECS Botanics Holdings Ltd (ECS) — FAQ
What is ECS Botanics Holdings Ltd's market cap?
ECS Botanics Holdings Ltd (ECS) has a reported market cap of $7.98M (data as of 2026-05-24).
What is ECS's P/E ratio?
The price-to-earnings (P/E) ratio for ECS Botanics Holdings Ltd (ECS) is 18.00 (data as of 2026-05-24).
Does ECS Botanics Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for ECS Botanics Holdings Ltd (ECS). Check the MyAverix Finance app for the latest dividend data.
What sector is ECS Botanics Holdings Ltd in?
ECS Botanics Holdings Ltd (ECS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ECS listed on?
ECS is listed on AU.
What is ECS Botanics Holdings Ltd's net margin?
ECS Botanics Holdings Ltd (ECS) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.